ebook Munafa Stock Market Course + Intraday & FNO calls  

       

JNCE announcements Jounce Therapeutics, Inc. announcements and dividends declared NASDAQ

Jounce Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Jounce Therapeutics, Inc. JNCE

Jounce Therapeutics, Inc. JNCE listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Jounce Therapeutics, Inc. JNCE

Tang Capital Partners Now Owns 10.20% of Jounce Therapeutics (JNCE)
Fintel reports that Tang Capital Partners has filed a 13D form with the SEC disclosing ownership of 5.30MM shares of Jounce Therapeutics Inc (JNCE). This represents 10.2% of the company.
Announcement as on 14 March 2023

: Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating account
Shares of Jounce Therapeutics Inc. JNCE bounced 6.6% in premarket trading Monday, after the immunotherapy company said only about .6 million, or 1.4% of its total cash and cash equivalents was in an operating account at SVB Financial Group’s SIVBSilico
Announcement as on 13 March 2023

Gilead To Acquire Remaining Rights To Immunotherapy GS-1811 From Jounce Therapeutics
(RTTNews) - Gilead Sciences, Inc. (GILD) and Jounce Therapeutics, Inc. (JNCE) amended their existing license agreement for GS-1811, enabling Gilead to buy out remaining contingent payments potentially due under the license agreement executed in August 2020
Announcement as on 27 December 2022

Announcements by Jounce Therapeutics, Inc. first page |

JNCE Jounce Therapeutics, Inc. current price & indicator signals

Moving Averages for Jounce Therapeutics, Inc.

  • 5Day Average: 1.92
  • 12Day Average: 1.92
  • 20Day Average: 1.91
  • 50Day Average: 1.59
  • 100Day Average: 1.33
  • 150Day Average: 1.4
  • 200Day Average: 1.96

JNCE Indicators & signals

Indicator MACD (12,26,9)

1.91, 1.82, 0.11
Indicator MACD is in positive zone

Indicator ADX (14)

0, 77.78, 77.78
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of JNCE Jounce Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Wed May 2023 1.88 1.88 to 1.93 -2.59% 11.84 times
02 Tue May 2023 1.93 1.91 to 1.93 0.52% 2.38 times
01 Mon May 2023 1.92 1.91 to 1.94 -0.52% 1.95 times
28 Fri Apr 2023 1.93 1.92 to 1.95 -0.52% 0.65 times
27 Thu Apr 2023 1.94 1.91 to 1.95 0.52% 0.82 times
26 Wed Apr 2023 1.93 1.91 to 1.95 0% 1.13 times
25 Tue Apr 2023 1.93 1.93 to 1.96 1.58% 0.89 times
24 Mon Apr 2023 1.90 1.90 to 1.92 -0.52% 0.29 times
21 Fri Apr 2023 1.91 1.90 to 1.92 0% 0.6 times
20 Thu Apr 2023 1.91 1.90 to 1.92 0.53% 0.46 times
19 Wed Apr 2023 1.90 1.90 to 1.92 0% 0.83 times
18 Tue Apr 2023 1.90 1.90 to 1.94 -1.04% 0.58 times

Videos related to: JNCE announcements Jounce Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

JNCE announcements Jounce Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top